Cardiology overview cardiomyopathy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 7: | Line 7: | ||
===Prognosis=== | ===Prognosis=== | ||
* The myosin binding proteins C genetic variant carries a good prognosis. | * The myosin binding proteins C genetic variant carries a good prognosis. | ||
* The presence of VT / VF carries the poorest prognosis. Outflow gradient is also related to prognosis. | |||
===Treatment=== | ===Treatment=== | ||
Revision as of 22:47, 31 October 2011
|
Cardiology Overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Hypertrophic Obstructive Cardiomyopathy
Screening
- Athletes should be screened using a family history of sudden death and a murmur on physical examination. Electrocardiograms and echocardiograms are not cost effective in this population.
Prognosis
- The myosin binding proteins C genetic variant carries a good prognosis.
- The presence of VT / VF carries the poorest prognosis. Outflow gradient is also related to prognosis.
Treatment
- Atrial fibrillation should be managed with amiodarone